Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan for vasospastic angina
NL-OMON55720Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of macitentan in Coronary vasospasm (CAS), sponsored by Amsterdam University Medical Center. Started Nov 2019; status: active, not recruiting.
02
Drugs
macitentan
03
Conditions
Coronary vasospasm (CAS)
Beyond the preview
Go deeper on NL-OMON55720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55720.